Phase 3 Archives

Browsing: Phase 3

Enhertu DESTINY-Breast06 Phase III Study the Impact on HR-Positive, HER2-Low Metastatic Breast Cancer Revealed

Breast 4 Mins Read154

Introduction The recent findings from the DESTINY-Breast06 Phase III trial signify a potential shift in the treatment landscape for HR-positive,…

Phase 3 EMBARK: Enzalutamide + Leuprolide Prostate Cancer ESMO 2023

Prostate 2 Mins Read4

By: Neal Shore, MD Date: October 25, 2023 In the abstract describing the EMBARK Phase 3 trial, Dr. Neal Shore…

FDA Grants Full Approval for Mirvetuximab Soravtansine-gynx (Elahere) for FRα positive, platinum-resistant epithelial ovarian with Robert Coleman, MD

Ovarian 4 Mins Read5

The recent approval by the Food and Drug Administration (FDA) of mirvetuximab soravtansine-gynx (Elahere) marks a significant advancement in the…

UGN-102 – Top line Phase 3 study results – Mark Schoenberg, MD

Bladder 3 Mins Read3

Mark Schoenberg, MD- UrologyGenitourinary (GU) CancerBladder Cancer-The Montefiore Medical Center and The Albert Einstein College of Medicine at UroGen Pharma…

Atezolizumab SBRT S1914 SWOG Phase 3 Results [2022]

Non-Small Cell Lung Cancer 8 Mins Read3

Does Atezolizumab SBRT Improve Progression-Free Survival In NSCLC? Atezolizumab is an immune checkpoint inhibitor that targets PDL-1. It has been…